Home
About Us
About Gentolex
Factory Tour
Culture
FAQs
Products
Chemicals
Chemical Intermediates
Organic Chemicals
Inorganics Chemicals
Catalysts and Auxiliaries
Pharma Ingredients
Pharma APIs
Anti-Infective
Cardiovascular System
Other Apis
Reproductive System
Secretion System
Pharma Intermediates
Amino Acids
Cosmetics Peptide
Service
Procurement Service
CRO&CDMO
NEWS ROOM
Contact Us
English
Home
News
News
Tadalafil Application
by admin on 22-07-25
Tadalafil is a medication used to treat erectile dysfunction and certain symptoms of an enlarged prostate. It works by improving blood flow to the penis, enabling a man to achieve and maintain an e...
Read more
Does growth hormone slow or accelerate aging?
by admin on 22-07-22
GH/IGF-1 decreases physiologically with age, and these changes are accompanied by fatigue, muscle atrophy, increased adipose tissue, and cognitive deterioration in the elderly… In 1990, Rudma...
Read more
New Products Alert
by admin on 22-07-21
In order to provide more options to the clients in Cosmetic peptides industry, Gentolex will constantly add new products to the list. High quality with varieties categories, there are totally four ...
Read more
Acadia Trofinetide Phase III Clinical Top-Line Results Positive
by admin on 22-02-17
On 2021-12-06, US time, Acadia Pharmaceuticals (Nasdaq: ACAD) announced the positive top-line results of its Phase III clinical trial of its drug candidate, Trofinetide. The phase III trial, called...
Read more
The research progress of opioid peptides from the approval of Difelikefalin
by admin on 22-02-17
As early as 2021-08-24, Cara Therapeutics and its business partner Vifor Pharma announced that its first-in-class kappa opioid receptor agonist difelikefalin (KORSUVA™) was approved by the FDA for ...
Read more
RhoVac Cancer Peptide Vaccine RV001 to be Patented by the Canadian Intellectual Property Office
by admin on 22-02-17
Canada time 2022-01-24, RhoVac, a pharmaceutical company focused on tumor immunology, announced that its patent application (No. 2710061) for its cancer peptide vaccine RV001 will be authorized by ...
Read more
Hit enter to search or ESC to close
English
French
German
Portuguese
Spanish
Russian
Japanese
Korean
Arabic
Irish
Greek
Turkish
Italian
Danish
Romanian
Indonesian
Czech
Afrikaans
Swedish
Polish
Basque
Catalan
Esperanto
Hindi
Lao
Albanian
Amharic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Bulgarian
Cebuano
Chichewa
Corsican
Croatian
Dutch
Estonian
Filipino
Finnish
Frisian
Galician
Georgian
Gujarati
Haitian
Hausa
Hawaiian
Hebrew
Hmong
Hungarian
Icelandic
Igbo
Javanese
Kannada
Kazakh
Khmer
Kurdish
Kyrgyz
Latin
Latvian
Lithuanian
Luxembou..
Macedonian
Malagasy
Malay
Malayalam
Maltese
Maori
Marathi
Mongolian
Burmese
Nepali
Norwegian
Pashto
Persian
Punjabi
Serbian
Sesotho
Sinhala
Slovak
Slovenian
Somali
Samoan
Scots Gaelic
Shona
Sindhi
Sundanese
Swahili
Tajik
Tamil
Telugu
Thai
Ukrainian
Urdu
Uzbek
Vietnamese
Welsh
Xhosa
Yiddish
Yoruba
Zulu
Kinyarwanda
Tatar
Oriya
Turkmen
Uyghur